Heavy! China’s novel coronavirus inactivated vaccine has been approved for use in people aged 3 to 17

In July 16th, the official WeChat official of China biological organization was organized by the relevant departments of the State Council joint defense and joint control mechanism to organize the demonstration of the COVID-19 group inactivated vaccine of the National Biological Products Research Institute of Beijing, China

.

China’s novel coronavirus inactivated vaccine was approved to be used in the 3-17 year old crowd

.

The new age of China’s new biological crown vaccine, the 3-17 year old age group, is already in use

.

Henan completed the phase I / II clinical trial

.

The positive conversion rate of neutralizing antibody after immunization in the population aged 3-17 years was 100%, and there was no significant difference in GMT and positive conversion rate of neutralizing antibody compared with the adult group

.

The safety after vaccination was good

.

The adverse reactions were mainly fever and pain at the vaccination site

.

The severity was grade 1

.

There was no serious adverse reaction

.

The incidence of adverse reactions gradually decreased with the increase of vaccination times   More news   Attention, diners! The small pond bears too much! Source: China biology (ID: cnbg1919), producer of Xinhua News Agency: Mou Yanqiu, Chen Jingchun, editor: Dong Jingxue, proofreader: Gui Ting, intern: Zheng Yuantai.

.